Intravenous rifampicin for persistent staphylococcal bacteremia in premature infants.
Soraisham
Amuchou Singh
AS
Division of Neonatology, Department of Pediatrics, University of Calgary, Alberta, Canada. amuchou@yahoo.com
Al-Hindi
Mohammed Yasir
MY
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007262:Infusions, Intravenous; D008297:Male; D019384:Nucleic Acid Synthesis Inhibitors / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014640:Vancomycin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D019384:Nucleic Acid Synthesis Inhibitors; D014640:Vancomycin; D012293:Rifampin